ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

AGL

Angle (AGL)

Angle Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AGL
DateTimeSourceHeadlineSymbolCompany
01/22/202412:03PMAlliance NewsAlliance NewsIN BRIEF: Angle highlights supportive data for DNA analysis toolLSE:AGLAngle Plc
01/22/20241:00AMRNS Non-RegulatoryAngle PLC Potential utility in precision oncologyLSE:AGLAngle Plc
01/10/20246:57AMUK Regulatory (RNS & others)Angle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
01/04/20246:19AMAlliance NewsAlliance NewsAngle shares soar following "breakthrough" cancer diagnostics resultsLSE:AGLAngle Plc
01/04/20243:10AMDow Jones NewsAngle PLC Shares Rise on Cancer Patient Blood Sample AnalysisLSE:AGLAngle Plc
01/04/20241:00AMUK Regulatory (RNS & others)Angle PLC Breakthrough clinical resultsLSE:AGLAngle Plc
01/02/20242:51AMAlliance NewsAlliance NewsIN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trialLSE:AGLAngle Plc
01/02/20241:00AMUK Regulatory (RNS & others)Angle PLC Contract announcement with Eisai Inc.LSE:AGLAngle Plc
12/11/20232:44PMAlliance NewsAlliance NewsTRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placingLSE:AGLAngle Plc
12/11/20231:00AMRNS Non-RegulatoryAngle PLC Parsortix unlocks opportunities for drug discoveryLSE:AGLAngle Plc
12/11/20231:00AMUK Regulatory (RNS & others)Angle PLC Broker AnnouncementLSE:AGLAngle Plc
12/05/20235:50AMAlliance NewsAlliance NewsIN BRIEF: Angle launches diagnostic kit at cancer symposiumLSE:AGLAngle Plc
12/05/20231:00AMRNS Non-RegulatoryAngle PLC ANGLE launches Portrait+ CTC kit at SABCSLSE:AGLAngle Plc
11/09/20238:29AMAlliance NewsAlliance NewsAngle says build up of revenue slower than hoped; launches testLSE:AGLAngle Plc
11/09/20231:00AMRNS Non-RegulatoryAngle PLC Launch of PD-L1 test to support cancer studiesLSE:AGLAngle Plc
11/09/20231:00AMUK Regulatory (RNS & others)Angle PLC Trading and business updateLSE:AGLAngle Plc
10/25/202311:28AMAlliance NewsAlliance NewsTRADING UPDATES: Franchise Brands trading in line; Tribe secures loanLSE:AGLAngle Plc
10/25/20231:00AMRNS Non-RegulatoryAngle PLC Supporting characterisation of CTCs in HNSCCLSE:AGLAngle Plc
10/03/20237:02AMAlliance NewsAlliance NewsAngle hails study which shows Parsortix outperforming lab standardLSE:AGLAngle Plc
10/03/20231:00AMRNS Non-RegulatoryAngle PLC Parsortix outperforms standard for DTC harvestLSE:AGLAngle Plc
09/29/20231:00AMRNS Non-RegulatoryAngle PLC Parsortix system showcased at ACTC conferenceLSE:AGLAngle Plc
09/07/20238:41AMAlliance NewsAlliance NewsEARNINGS UPDATES: Sylvania beats production goal, Angle revenue surgesLSE:AGLAngle Plc
09/07/20231:00AMUK Regulatory (RNS & others)Angle PLC Interim Results for the period ended 30 June 2023LSE:AGLAngle Plc
09/04/20238:21AMAlliance NewsAlliance NewsAngle launches tumour cell assay to "unlock" customised cancer careLSE:AGLAngle Plc
09/04/20231:00AMRNS Non-RegulatoryAngle PLC ANGLE launch of Portrait Flex assayLSE:AGLAngle Plc
08/15/20231:00AMUK Regulatory (RNS & others)Angle PLC ANGLE notice of interim resultsLSE:AGLAngle Plc
06/28/202310:54AMUK Regulatory (RNS & others)Angle PLC Result of 2023 Annual General MeetingLSE:AGLAngle Plc
06/27/20236:24AMUK Regulatory (RNS & others)Angle PLC Standard form for notification of major holdingsLSE:AGLAngle Plc
06/05/20236:26AMAlliance NewsAlliance NewsIN BRIEF: Angle hires Swansiger as new COO and Miller as new CSOLSE:AGLAngle Plc
06/05/20231:00AMRNS Non-RegulatoryAngle PLC ANGLE announces senior management appointmentsLSE:AGLAngle Plc
 Showing the most relevant articles for your search:LSE:AGL
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com